CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida Biosciences Inc. (AlidaBio), a…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
